The last decade of the twentieth century Russian pharmaceutical market is flooded as modern drugs and their equivalents, issued by companies under various trade names. And their prices differ sharply.
With a lack of funding public health care, many drugs have become available much of the population of the Russian Federation, more frequent purchases significantly cheaper generics, generics - analogs of drugs expensive. According to the WHO, more and more developing countries and countries with budget deficits in the health resort to this recourse.
As you know, the latest active ingredients for pharmaceuticals developed by the research centers of large pharmaceutical companies and research firms specializing in drug discovery. The process of developing a new original drug is laborious, takes an average of 5 to 15 years and cost hundreds of millions of dollars. The validity of a patent is 20 years.
Thereafter, any pharmaceutical company, registered and certified, can obtain the right to produce its own drug, and the active component is yavlyaetsya the same substance. But it will be Generic - generics .
According to the World Health Organization (WHO) generics - Is reproduced drugs are interchangeable with their proprietary counterparts introduced (sold) on the market after expiry of patent protection for the corresponding patented drug. Generics are a copy of the original drugs, the term of a patent which had already expired, and they are produced in strict compliance with all existing rules and standards.
Production of generic drugs is much less expensive than the original drug. The advantages generics It includes not only low cost, but high (over 20 years) clinical experience.
For example, a proprietary drug Aspirin Bayer - very expensive, but all the other tablet form, the active ingredient of which is acetylsalicylic acid, are considered to be generic and cost a penny.
Experts note that the new drugs are more effective and, therefore, should provide a better quality of life for patients, as developed when conventional drugs do not give positive results.
In our country, this problem is very urgent, because the constantly marked lack of modern Russian analogs of drugs foreign production, plus the doctors usually do not have adequate information about the replacement of expensive drugs for quality, but cheap domestic generics.
Of course, the doctor must be sure that such substitution will not cause damage to the health of the patient. Replacement drugs should be strictly therapeutically equivalent, that is the main feature of a high-quality generics. This is achieved by constant quality control of the drug.
Benefits generics expressed in that:
- Cost generics are always much lower than the original products, ie they are more accessible to patients with low and average incomes;
- analogs of drugs allow doctors to prescribe adequate therapy even in underdeveloped countries, this use of modern generics expensive original drugs;
- Generics allow the physician and patient choice;
- The emergence of a large number of generics in the pharmaceutical market is the main factor forcing the company as much as possible to implement new promising projects.
- They are well studied in terms of efficacy and safety.
For our country, the use of generic drugs in clinical practice is the output in the current difficult situation of providing drugs of the Russian population, especially those with low and middle-income countries.
Indicative is the fact that in Russia, according to statistics, among the leaders turned 12 original products, generics and 10 8 complex medicines. In the United States, in contrast, provide the greatest momentum original medicinal drugs.
However, generic drugs are the leaders on the Russian pharmacy market only if they have no rivals among the well-proven original preparations. Of course, most are related to non-prescription drugs. This is likely the result of a massive advertising of specific brands of drugs.
Compete with the original drugs with the widely advertised brands are only capable of high quality branded generics, whose names also began to acquire strength of the brand.
Pharmacists predict that generic companies will continue to compete for space on the Russian pharmaceutical market, and advances in medical science will become more accessible for the population of Russia.
Oksana Herasymenko
Treatment and prevention
Go back to the main page